MARKET

RDY

RDY

Dr.Reddys
NYSE

Real-time Quotes | Nasdaq Last Sale

44.85
-0.80
-1.75%
After Hours: 44.85 0 0.00% 16:00 02/20 EST
OPEN
45.22
PREV CLOSE
45.65
HIGH
45.34
LOW
44.31
VOLUME
97.57K
TURNOVER
--
52 WEEK HIGH
46.19
52 WEEK LOW
34.67
MARKET CAP
7.43B
P/E (TTM)
32.86
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of RDY and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Underperform

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

RDY News

  • Risks Remain, but Amarin Stock Is a Buy at Today’s Prices
  • InvestorPlace.6d ago
  • The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering
  • Benzinga.6d ago
  • Dr. Reddy's Laboratories to Acquire Select Business Divisions of Wockhardt in India for Rs.1850 Crores
  • Benzinga.02/12 10:01
  • Dr. Reddy's Laboratories Announces the Launch of Trientine Hydrochloride Capsules USP, 250 mg, in the U.S. Market
  • Business Wire.02/07 08:02

More

Industry

Pharmaceuticals
-0.54%
Pharmaceuticals & Medical Research
-0.40%

Hot Stocks

Name
Price
%Change

About RDY

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.
More

Webull offers Dr.Reddy's Laboratories Ltd (ADR) (RDY) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.